Exact Sciences' Cologuard Cancer Test Debuts

Search Results - La Crosse Tribune, La Crosse Tribune
Sun, 08/31/2014 - 6:15am

The Madison company starts selling its non-invasive screening test for colorectal cancer.

Sections: u.s.

Powerball jackpot grows to $386 million after no winner Monday. See winning numbers for Aug. 30.
Powerball jackpot continues to grow after no winner Monday. See cash out amount and Wednesday's winning numbers. More
Check out action from FVL vs Xavier girls volleyball
FVL girls volleyball plays against Xavier High School More
Republicans introduce bills to address the state's child care shortage, but Democrats say they fall short
The legislation provides a tax deduction for child care costs and loosens regulations. Democrats say the measures could create safety problems. More
See photos from Jackson Elementary's new accessible playground in Green Bay
The playground is the first accessible playground in the Green Bay School District. It has a spongy, flat ground for students of all abilities. More
UW-La Crosse Chancellor Joe Gow is stepping down. What he's learned in 17 years on the job
Joe Gow, who started the job in 2007, plans to transition to a faculty role and teach communication studies. More

BING NEWS:

FDA panel gives nod to blood test for colon cancer
A U.S. Food and Drug Administration advisory panel on Thursday recommended the approval of a new blood test that can spot colon cancer.
05/26/2024 - 1:40 am | View Link
Stephens Upgrades Guardant Health Inc. to Buy
Stephens upgraded Guardant Health to Buy from Hold, following a strong FDA panel recommendation for its colon cancer screening test, Shield. The FDA panel’s endorsement of Shield highlights its ...
05/25/2024 - 11:00 pm | View Link
Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok
Shares of Guardant Health were up 8% Friday morning after an advisory panel to the U.S. Food and Drug Administration endorsed the company’s blood test to detect colorectal cancer. A solid majority of ...
05/24/2024 - 3:20 pm | View Link
Guardant Health Jumps — As Exact Sciences Slumps — On A Key FDA Move For Blood Tests
Guardant Health stock jumped Friday after an FDA panel recommended the agency approval Guardant's blood-based colon cancer screening test.
05/24/2024 - 9:09 am | View Link
New Blood Test for Colon Cancer Early Detection Gets FDA Panel Nod
FDA advisory group approves Shield blood test for colon cancer, aiming to improve screening rates and reduce preventable deaths among average-risk patients.
05/24/2024 - 8:54 am | View Link
More

MoviesWithButter : Our Sister Site